欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4002/002
药品名称Dasatinib Sandoz 50 mg, filmomhulde tabletten
活性成分
    • Dasatinib 50.0 mg
剂型Film-coated tablet
上市许可持有人Sandoz B.V. Hospitaaldreef 29 1315 RC Almere Nederland
参考成员国 - 产品名称Netherlands (NL)
Dasatinib Sandoz 50 mg, filmomhulde tabletten
互认成员国 - 产品名称
    • Czechia (CZ)
      Dasatinib Sandoz
    • Denmark (DK)
      Dasatinib "Sandoz"
    • Estonia (EE)
    • Norway (NO)
    • Germany (DE)
      Dasatinib PharOS 50 mg Filmtabletten
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Finland (FI)
    • Poland (PL)
      Dasatinib Sandoz
    • Hungary (HU)
      DASATINIB SANDOZ 50 mg filmtabletta
    • Bulgaria (BG)
      Dasatinib PharOS
    • Romania (RO)
      Dasatinib Sandoz 50 mg comprimate filmate
    • Slovakia (SK)
      Dasatinib PharOS 50 mg
    • Slovenia (SI)
      Dasatinib Sandoz 50 mg filmsko obložene tablete
许可日期2018/07/25
最近更新日期2025/09/19
药物ATC编码
    • L01XE06 dasatinib
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase